Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.
Debureaux PE, Forgeard N, Elessa D, Harel S, Frenzel L, Royer B, Talbot A, Choquet S, Davi F, Nguyen-Khac F, Cuccuini W, Cheminant M, Bravetti C, Lazarian G, Kaltenbach S, Hermine O, Roos-Weil D, Espéli M, Balabanian K, Arnulf B.
Debureaux PE, et al. Among authors: harel s.
Haematologica. 2024 Jan 1;109(1):325-330. doi: 10.3324/haematol.2023.283141.
Haematologica. 2024.
PMID: 37584289
Free PMC article.
No abstract available.